Form 4: Director Ronald J. Packard Acquires Stock Options in Harvard Apparatus Regenerative Technology, Inc.
SEC Form 4 Filing
Ronald J. Packard, a director of Harvard Apparatus Regenerative Technology, Inc., acquired stock options through an equity grant and in lieu of cash compensation.
Summary
- On June 27, 2024, Ronald J. Packard, a director of Harvard Apparatus Regenerative Technology, Inc. (HRGN), acquired stock options.
- He received 10,204 stock options as an annual equity grant, vesting in four equal installments on September 27, 2024, December 27, 2024, March 27, 2025, and June 27, 2025.
- Additionally, he acquired 8,215 stock options in lieu of cash compensation, vesting in four equal installments on June 27, 2024, June 30, 2024, September 30, 2024, and December 31, 2024.
- The exercise price for both stock option grants is $2.92 per share, and they expire on June 27, 2034.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard disclosure of stock option grants to a director, neither particularly positive nor negative.
Positives
- The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
This filing is a routine disclosure related to director compensation and equity ownership, common in publicly traded companies.
Comparison to Industry Standards
- Director compensation packages often include stock options to align their interests with those of shareholders.
- The vesting schedules and exercise prices are typical for such grants.
Stakeholder Impact
- The granting of stock options aligns the director's interests with those of shareholders, potentially encouraging decisions that increase shareholder value.
Key Dates
| Date | Description |
|---|---|
| 06/27/2024 | Date of transaction: Director Ronald J. Packard acquired stock options. |
| 06/27/2024 | Date of first vesting installment for options granted in lieu of cash compensation. |
| 06/30/2024 | Date of second vesting installment for options granted in lieu of cash compensation. |
| 09/27/2024 | Date of first vesting installment for annual equity grant options. |
| 09/30/2024 | Date of third vesting installment for options granted in lieu of cash compensation. |
| 12/27/2024 | Date of second vesting installment for annual equity grant options. |
| 12/31/2024 | Date of fourth vesting installment for options granted in lieu of cash compensation. |
| 03/27/2025 | Date of third vesting installment for annual equity grant options. |
| 06/27/2025 | Date of fourth vesting installment for annual equity grant options. |
| 06/27/2034 | Expiration date for both stock option grants. |
| 07/15/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.